Fig. 1
From: Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy

a Representative in vivo real-time imaging of the orthotopic glioma model administered with different nanoparticles. b Ex vivo imaging of the accumulation of nanoparticles in various organs. c Ex vivo imaging and d semi-quantitative fluorescence intensity of glioma-bearing brain (data are the mean ± SD, n = 3). *P < 0.05 and **P < 0.01